It differs regarding the bone marrow architecture evaluated under microscope.
Too much to talk about here at the forum
Practically: AML ‘de novo’ (brand-new) arises within weeks, AML secondary to MDS needs at least months. Even if it is freshly diagnosed it can be easily distinguished in the slides whether this is either ‘de novo’ AML or AML secondary to MDS.
Briefly: The AML Classification you mentioned is FAB Classification and apply to the types M0 to M7 according to the level of the marrow cells differentiation. Nowadays in treatment and in prognosis more important are the specific chromosomal mutations than the FAB subtypes of AML.